Fact CheckerSign in

NCT05480904Active, not recruiting

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
199 (estimated)
First submitted
19 Jul 2022
Start date
17 Apr 2023
Primary completion date
29 Apr 2026
Lead sponsor
St. Jude Children's Research Hospital
NCT number
NCT05480904

What you commit to

  • Study type: Observational
  • Planned participants: 199
  • From 17 Apr 2023 to the primary completion date, 29 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Relapsed or treated with hematopoietic stem cell therapy.

Other illness

  • Currently prescribed an intervention for a sleep disorder.
  • Brain injury unrelated to cancer diagnosis or therapy.
  • Pulmonary injury unrelated to cancer diagnosis or therapy.

Other

  • Estimated intelligence score \<80.
  • Survivor of craniopharyngioma.
  • Survivor of Hodgkin Lymphoma.

Who the study is looking for

  • Participant in SJLIFE and \> 5 years from diagnosis.
  • \>18 years of age at time of enrollment.
  • Diagnosed with ALL (treated with CRT or chemotherapy only) or CNS tumors (posterior fossa tumors or supratentorial tumors) or non-CNS solid tumors (with abdominal or chest radiation or bilateral retinoblastoma survivors).
  • Participant was less than 21 years of age at time of diagnosis.
  • Speaks and understands English (polysomnography device speaks to patients only in English).
  • Remote participant must have Wi-Fi access

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
St. Jude Children's Research Hospital
Coordinator of this site? Confirm its status
MemphisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.